Intraoperative infiltration of ropivacaine has no effect on morphine consumption after THA .
This report has been verified
by one or more authors of the
original publication.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2014;2(10):6 Br J Anaesth. 2014 Apr;112(4):722-8. doi: 10.1093/bja/aet439. Epub 2014 Jan 14.60 patients undergoing primary total hip arthroplasty (THA) were randomized to receive single-shot intraoperative infiltration of ropivacaine alone or saline. The purpose of this study was to determine the efficacy of ropivacaine alone in the management of morphine consumption and postoperative pain in these patients. Results indicated that no significant differences were observed between groups in 24-hour morphine consumption, cumulative morphine consumption, postoperative and chronic pain, hyperalgesia surfaces, surgical result, morphine-related side-effects or rehabilitation progress.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
